Skip to content
Clinical Trials – home
Research site

Centre Hospitalier De Tourcoing

France 155 Rue Du President Coty, Bp 40619, 59208 Tourcoing, France

  • 16 trials recruiting
  • HIV infection · Arteriosclerosis · Medical device site joint infection
  • Adults and children

About Specializations

Centre Hospitalier De Tourcoing in Tourcoing, France specialises in clinical trials of conditions such as HIV infection, Arteriosclerosis, Medical device site joint infection, Septic shock, and other specialisations. This site conducts important research.

Main research areas of the site

Neurology and Hematology

The medical center is at the forefront of research in neurology and hematology, focusing on innovative strategies for managing intracerebral hemorrhage. The center's research aims to evaluate the efficacy of different therapeutic approaches, including the use of oral anticoagulants and left atrial appendage closure, to improve patient outcomes.

  • Intracerebral Hemorrhage Management
  • Anticoagulation Strategies
  • Clinical Outcome Improvement

Through its research, the center contributes to the development of personalized treatment plans that enhance the quality of life for patients with complex neurological conditions.

Infectious Diseases and Orthopedics

Specializing in the intersection of infectious diseases and orthopedics, the center explores the efficacy of novel antibiotic regimens for prosthetic joint infections. By investigating the use of dalbavancin in combination with other antibiotics, the center aims to improve treatment protocols for infections associated with joint prostheses.

  • Prosthetic Joint Infection Treatment
  • Antibiotic Efficacy Studies
  • Staphylococcal Infections

The research conducted here is pivotal in reducing infection rates and enhancing recovery for patients undergoing joint replacement surgeries.

Respiratory and Viral Infections

The center is a leader in the study of respiratory infections, particularly in the context of COVID-19. Through the STRIVE platform, the center evaluates the safety and efficacy of various therapeutic interventions, aiming to improve clinical recovery and reduce mortality among hospitalized patients.

  • COVID-19 Treatment Strategies
  • Immune Modulation
  • Acute Respiratory Infection Management

This research is instrumental in shaping global health responses to viral emergencies and enhancing patient care protocols.

Oncology and Surgical Innovations

Focusing on oncology and surgical innovations, the center investigates the role of corticosteroids in reducing complications post-surgery for digestive cancer. This research aims to optimize surgical outcomes and minimize postoperative risks.

  • Digestive Cancer Surgery
  • Preoperative Corticosteroid Use
  • Complication Reduction

The center's work in this area is crucial for advancing surgical techniques and improving recovery rates for cancer patients.

HIV and Antiretroviral Therapy

Renowned for its contributions to HIV research, the center evaluates the efficacy of novel antiretroviral therapies, including bictegravir and lenacapavir. The focus is on maintaining viral suppression and improving long-term health outcomes for individuals living with HIV.

  • Antiretroviral Therapy Innovations
  • Virological Suppression
  • HIV Treatment Optimization

The center's research efforts are pivotal in developing more effective and sustainable treatment regimens for HIV patients worldwide.

Sexually Transmitted Infections

In the realm of sexually transmitted infections, the center conducts groundbreaking research on the treatment of early syphilis. By comparing different antibiotic regimens, the center aims to establish more effective treatment protocols and improve patient outcomes.

  • Syphilis Treatment Strategies
  • Antibiotic Efficacy
  • Infection Control

This research is essential for enhancing public health strategies and reducing the prevalence of sexually transmitted infections.

Gastroenterology and Autoimmune Disorders

The center excels in gastroenterology research, particularly in the management of ulcerative colitis. By exploring the impact of telemonitoring and patient education on treatment outcomes, the center seeks to improve disease management and patient quality of life.

  • Ulcerative Colitis Management
  • Telemonitoring in Healthcare
  • Patient Education

The center's innovative approaches are transforming the way chronic gastrointestinal disorders are treated and managed.

Sepsis and Critical Care

Specializing in sepsis and critical care, the center investigates the role of vitamin C in reducing organ dysfunction in patients with septic ARDS. This research is crucial for developing new therapeutic strategies to improve survival rates in intensive care settings.

  • Septic ARDS Treatment
  • Vitamin C Therapy
  • Organ Dysfunction Reduction

The center's work in this area is vital for advancing critical care medicine and enhancing patient outcomes in life-threatening conditions.

Neurodegenerative Diseases

In the field of neurodegenerative diseases, the center focuses on the impact of caffeine on cognitive decline in Alzheimer's disease. By evaluating the potential benefits of caffeine supplementation, the center aims to develop new interventions for slowing disease progression.

  • Alzheimer's Disease Research
  • Cognitive Decline Prevention
  • Neuroprotective Strategies

The center's research is instrumental in uncovering new therapeutic avenues for patients with neurodegenerative disorders.

Renal and Metabolic Disorders

Focusing on renal and metabolic disorders, the center explores the effects of vitamin B3 supplementation in preventing kidney events during septic shock. This research is pivotal in developing strategies to protect renal function in critically ill patients.

  • Septic Shock Management
  • Renal Protection Strategies
  • Vitamin B3 Efficacy

The center's findings contribute to the advancement of treatment protocols for metabolic and renal complications in intensive care.

Immunology and Gastroenterology

In the domain of immunology and gastroenterology, the center investigates the comparative efficacy of azathioprine and methotrexate in combination with adalimumab for Crohn's Disease. This research aims to optimize therapeutic regimens and improve patient outcomes.

  • Crohn's Disease Treatment
  • Combination Therapy Efficacy
  • Endoscopic Response Improvement

The center's work is crucial for advancing the treatment of autoimmune gastrointestinal disorders and enhancing patient care.

Phage Therapy and Orthopedic Infections

The center is pioneering research in phage therapy for orthopedic infections, particularly in cases of prosthetic joint infections due to Staphylococcus aureus. By evaluating the efficacy of bacteriophages in combination with antibiotics, the center aims to develop innovative treatment strategies.

  • Phage Therapy Innovations
  • Prosthetic Joint Infection Control
  • Staphylococcus aureus Management

The center's research is instrumental in reducing infection rates and improving outcomes for patients with complex orthopedic conditions.

Virology and Dermatology

In the fields of virology and dermatology, the center evaluates the efficacy of the HPV vaccine in preventing the recurrence of external genital warts. This research is essential for developing effective vaccination strategies and reducing the burden of viral skin infections.

  • HPV Vaccine Efficacy
  • Genital Wart Recurrence Prevention
  • Viral Infection Control

The center's work in this area is vital for enhancing public health initiatives and improving patient outcomes in dermatological care.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
155 Rue Du President Coty, Bp 4061959208 TourcoingFrance
Recruiting now
16 trials
Conditions studied
29

More sites in TourcoingFrance

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

41 clinical trials

HIV infection

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Emtricitabine
  • Sponsor:Merck Sharp & Dohme LLC
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Anakinra
  • Sponsor:Assistance Publique Hopitaux De Paris
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cefazolin Sodium
  • Sponsor:Centre Hospitalier Universitaire De Nantes
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dolutegravir
  • Sponsor:ANRS Maladies Infectieuses Emergentes
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Amoxicillin Sodium
  • Sponsor:Centre Hospitalier Universitaire Amiens Picardie
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Rifabutin
  • Sponsor:Centre Hospitalier De Tourcoing
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:Centre Hospitalier Universitaire Amiens Picardie
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Caffeine
  • Sponsor:Centre Hospitalier Universitaire De Lille
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ceftriaxone Sodium
  • Sponsor:Centre Hospitalier Universitaire Amiens Picardie
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Darunavir
  • Sponsor:Inserm
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
  • Sponsor:Assistance Publique Hopitaux De Paris
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Doravirine
  • Sponsor:Centre Hospitalier Universitaire De Caen Normandie
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.